Treatment Decision-Making Journey Map for Adults with Atopic Dermatitis: A Descriptive Qualitative Study.
- 1School of Nursing, Kunming Medical University, Kunming, Yunnan, People's Republic of China.
- 2Department of Dermatology, The First Affiliated Hospital of Kunming Medical University, Kunming, Yunnan, People's Republic of China.
- 3Department of Geriatrics, Yan'an Hospital of Kunming City, Kunming, Yunnan, People's Republic of China.
Abstract
Background
Adults with atopic dermatitis frequently make treatment-related decisions about symptom management, treatment, self-care, and relapse prevention, but how these decisions unfold across the course of a chronic and relapsing disease remains insufficiently understood.Objective
To map the treatment decision-making journey of adults with atopic dermatitis and identify stage-specific support needs from the patient perspective.Methods
A descriptive qualitative study was carried out in the dermatology department of a tertiary hospital in China. Thirteen adults with AD were purposively recruited. Data were collected through semi-structured interviews, observation, and desk research. Interview data were analyzed using directed content analysis guided by the Ottawa Decision Support Framework. Patient journey mapping was used to organize tasks, pain points, facilitating factors, emotions, decision-making needs, decision support, and decision quality across stages.Results
The treatment decision-making journey was divided into three phases: decision preparation, decision formation, and decision implementation/redecision, with 26 themes identified across tasks, pain points, facilitating factors, and emotions. As for how patients moved through this process, they first appraised their symptoms and carried out self-management, then compared different treatment options and weighed benefits against risks, and after that came the actual implementation of treatment along with outcome evaluation; once a relapse occurred, they would face the need for redecision.Conclusions
Treatment decision-making in atopic dermatitis is dynamic, extending beyond initial treatment. Support should address symptom interpretation, treatment comparison, values clarification, implementation barriers, relapse management, and follow-up.
Related
- Patient challenges across the implant-based breast reconstruction journey: A qualitative descriptive study
- Mapping the symptom management journey across the treatment cycle for breast cancer patients: A qualitative study.
- A Journey Map of Health Behaviour Decision-Making Among Patients with Type 2 Diabetes Mellitus Who are Repeatedly Hospitalized: A Longitudinal Qualitative Study.
- Food-Related Decision-Making at Home After Recurrent Esophagogastric Variceal Bleeding in Patients with Cirrhosis: A Qualitative Descriptive Study.
- Illness narratives in treatment decision-making among adults with atopic dermatitis: implications for nurses’ clinical listening
BibTeX
@article{jin2026treatment,
title = {{Treatment Decision-Making Journey Map for Adults with Atopic Dermatitis: A Descriptive Qualitative Study.}},
author = {Yatong Jin and Zhicang Cui and Meng Zheng and Fanxian Zhu and Na Li},
journal = {Patient preference and adherence},
year = {2026},
month = nov,
doi = {10.2147/ppa.s642009},
url = {https://europepmc.org/article/MED/43011860},
note = {CC BY-NC},
}
RIS
TY - JOUR
TI - Treatment Decision-Making Journey Map for Adults with Atopic Dermatitis: A Descriptive Qualitative Study.
AU - Yatong Jin
AU - Zhicang Cui
AU - Meng Zheng
AU - Fanxian Zhu
AU - Na Li
PY - 2026
DA - 2026/11/06
JO - Patient preference and adherence
DO - 10.2147/ppa.s642009
UR - https://europepmc.org/article/MED/43011860
AB - Background Adults with atopic dermatitis frequently make treatment-related decisions about symptom management, treatment, self-care, and relapse prevention, but how these decisions unfold across the course of a chronic and relapsing disease remains insufficiently understood.Objective To map the treatment decision-making journey of adults with atopic dermatitis and identify stage-specific support needs from the patient perspective.Methods A descriptive qualitative study was carried out in the dermatology department of a tertiary hospital in China. Thirteen adults with AD were purposively recruited. Data were collected through semi-structured interviews, observation, and desk research. Interview data were analyzed using directed content analysis guided by the Ottawa Decision Support Framework. Patient journey mapping was used to organize tasks, pain points, facilitating factors, emotions, decision-making needs, decision support, and decision quality across stages.Results The treatment decision-making journey was divided into three phases: decision preparation, decision formation, and decision implementation/redecision, with 26 themes identified across tasks, pain points, facilitating factors, and emotions. As for how patients moved through this process, they first appraised their symptoms and carried out self-management, then compared different treatment options and weighed benefits against risks, and after that came the actual implementation of treatment along with outcome evaluation; once a relapse occurred, they would face the need for redecision.Conclusions Treatment decision-making in atopic dermatitis is dynamic, extending beyond initial treatment. Support should address symptom interpretation, treatment comparison, values clarification, implementation barriers, relapse management, and follow-up.
SN - 1177-889X
ER -